Wegovy is also approved to lower body weight in people with obesity (including adolescents age 12 and older), or adults who are overweight and have at least one weight-related condition such as high blood pressure, high cholesterol, or Type 2 diabetes
This strategy allows companies to innovate on the foundations of existing blockbusters like semaglutide and tirzepatide
In this trial, 342 men with sildenafil-failure ED were given either intranasal PT-141 (10 mg dose) or placebo on demand over ~48 weeks.The outcomes demonstrated a clear benefit of bremelanotide: About 33.5% of men on bremelanotide achieved a positive clinical response (improved erections sufficient for intercourse) compared to only 8.5% on placebo
In the pivotal STRATUM trial, nearly 80% of individuals achieved the primary efficacy endpoint of Investigators Global Assessment (IGA) Success, with just over 50% reaching complete clearance at week 8
Begin your personalized treatment plan Depending on your symptoms or conditions, we will begin our therapies at a recommended rhythm while monitoring your experience and results at every step